J. CHU Et Al. , "Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome," 57th Annual Meeting of the American-Society-of-Hematology , 2015
CHU, J. Et Al. 2015. Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome. 57th Annual Meeting of the American-Society-of-Hematology .
CHU, J., Henderson, L., Armant, M., Male, F., Dansereau, C., MacKinnon, B., ... Burke, C.(2015). Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome . 57th Annual Meeting of the American-Society-of-Hematology
CHU, JULIA Et Al. "Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome," 57th Annual Meeting of the American-Society-of-Hematology, 2015
CHU, JULIA Et Al. "Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome." 57th Annual Meeting of the American-Society-of-Hematology , 2015
CHU, J. Et Al. (2015) . "Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome." 57th Annual Meeting of the American-Society-of-Hematology .
@conferencepaper{conferencepaper, author={JULIA CHU Et Al. }, title={Gene Therapy Using a Self Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott Aldrich Syndrome}, congress name={57th Annual Meeting of the American-Society-of-Hematology}, city={}, country={}, year={2015}}